Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
Helminth therapy and multiple sclerosis.
Long-term clinical and magnetic resonance imaging outcomes from patients treated with teriflunomide: Results from a phase 2 extension study.
Siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis: Design of the phase 3 EXPAND trial.
ISMRM Workshop on Multiple Sclerosis as a Whole-Brain Disease
Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
Unusual case of gastroparesis leading to severe gastromegaly with demyelinating disease as a rare cause.
Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review.
Time limited immunomodulatory functions of transplanted neural precursor cells.
The American Academy of Neurology's Top Five Choosing Wisely recommendations.
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
First use of alemtuzumab in Balo's concentric sclerosis: a case report.
Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study.
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.
Genmab announces details of planned ofatumumab Phase II study in multiple sclerosis
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - A twelve month follow-up.
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.
Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier.
Mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses of amiloride hydrochloride, a new potassium-sparing diuretic.
Calpain inhibition attenuated morphological and molecular changes in skeletal muscle of experimental allergic encephalomyelitis rats.
Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica.
Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.
Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis.
Central Nervous System Herpes Simplex and Varicella-Zoster Virus Infections in Natalizumab-Treated Patients.
Genzyme’s Lemtrada Approved in Argentina for Treatment of Multiple Sclerosis

Pages